Europe's drug regulator on Thursday recommended adding a rare type of spinal inflammation called transverse myelitis as a side-effect of Johnson & Johnson's single-dose Covid-19 vaccine.

Reports of this serious neurological illness were also at the heart of trial halts in the early stages of development for both AstraZeneca and J&J's shots, which are based on similar technology...